| Sources | Names Used |
|---|---|
| CTRPv2 | Repligen 136 |
| PharmacoGx | Repligen 136 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CETN3 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | DCAF7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | UNC80 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | KIR2DL1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | ADCY3 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | RAB3GAP1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | CHRDL2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | C15orf38-AP3S2 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | PIGQ | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | YWHAZ | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
